Manning & Napier Group, LLC / BMRN
Manning & Napier Group, LLC’s Biomarin Pharmaceutical Inc Position
Does Manning & Napier Group, LLC own Biomarin Pharmaceutical Inc (BMRN)? Yes — 1.15M shares worth $101M (+1.15% of its 13F portfolio) as of Q1 2024, up from 1.15M shares the prior filed quarter.
Position Value
$101M
Q1 2024
Shares
1.15M
% of Portfolio
+1.15%
Quarters Held
21
currently held
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 1.15M | $101M | +1.15% |
| Q4 2023 | 1.15M | $110M | +1.31% |
| Q3 2023 | 1.14M | $101M | +1.25% |
| Q2 2023 | 1.14M | $99M | +1.13% |
| Q1 2023 | 1.10M | $107M | +1.25% |
| Q4 2022 | 874.6K | $91M | +1.11% |
| Q3 2022 | 931.8K | $79M | +1.03% |
| Q2 2022 | 946.4K | $78M | +0.91% |
| Q1 2022 | 1.71M | $131M | +1.25% |
| Q4 2021 | 1.74M | $153M | +1.28% |
| Q3 2021 | 1.74M | $135M | +1.16% |
| Q2 2021 | 1.73M | $144M | +1.18% |
| Q1 2021 | 1.70M | $129M | +1.09% |
| Q4 2020 | 1.08M | $95M | +0.88% |
| Q3 2020 | 1.13M | $86M | +0.87% |
| Q2 2020 | 970.5K | $120M | +1.28% |
| Q1 2020 | 1.05M | $89M | +1.05% |
| Q4 2019 | 1.10M | $93M | +1.00% |
| Q3 2019 | 730.1K | $49M | +0.55% |
| Q2 2019 | 726.1K | $62M | +0.68% |
| Q1 2019 | 911.0K | $81M | +0.89% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Manning & Napier Group, LLC’s full portfolio or all institutional holders of BMRN.